21719 results for «»
21719 results
Cases on complications of coronary perforation: STEMI & NSTEMI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to learn more about complications of coronary perforation, thanks to a selection of two challenging cases: a percutaneous ventricular support device absorbing guidewire during STEMI PCI, as well as a guidewire-induced perforation of tortuous small distal coronary artery.
Cases on complications: stable CAD, stents & scaffolds
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of cases on stable CAD, stents & scaffolds and learn more about how to cope with complications.
Cases on calcified lesions
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover various interesting cases on calcified lesions, such as a spiral coronary dissection due to intravascular balloon lithotripsy rupture, a CHIP case of recalcitrant coronary calcium, and more!
Cases on imaging
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of cases on imaging, and learn more about the prognostic utility of quantitative flow ratio in DEB-only PCI, the algorithmic approach for myocardial infarction with non-obstructive coronary arteries, as well as the advantages of OCT for primary PCI.
Abstracts on stable CAD and transradial access
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to learn more about the benefit/risk trade-off of extended DAPT in "TWILIGHT-like" patients after PCI, as well as the distal transradial access for coronary angiography and interventions.
Abstracts on TAVI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...
Abstracts on STEMI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover various papers in STEMI, and learn more about the higher rate of heart failure and in-hospital mortality in STEMI patients during COVID-19 era, the management and outcomes of STEMI patients with current technology, the outcomes of a registry regarding cardiogenic shock...
Abstracts: Use of balloons in Bifurcation Lesions
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on stents, scaffolds and DEB, and learn more about the outcome of balloon-embedded bifurcation stenting with single stent for side branch protection, the differences between biodegradable vs. durable polymer DES with short-term DATP, and more!
Abstracts on pharmacotherapy and vascular access
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover three abstracts on pharmacotherapy and vascular access: a molecular analysis of CYP2C19 alleles and clopidogrel resistance among Bangladeshi patients with ACS, a transradial vs. transfemoral approach in coronary angioplasty using rotational atherectomy, as well as a potential new interventional therapy with Phosphatidylcholine/deoxycholate to...
Abstracts on mitral valve repair
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover two abstracts on mitral valve repair, and learn more about the outcomes of aortic and tricuspid regurgitation after percutaneous mitral commissurotomy.
#1 - How are MitraClip experience and proven outcomes influencing real-life clinical practice?
19 Oct 2021
Discover the replay of this PCR Webinar on MitraClip with H. Ince, S. Kar, W. Rottbauer and R. von Bardeleben
Best cases and research unveiled at AICT-Asia PCR 2021
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to discover some of the best cases and research unveiled at AICT-Asia PCR 2021: positive remodelling of coronary arteries on CT coronary angiogram, investigation of heavy metals in coronary artery tissues in autopsy cases, DEB vs. DES in the main vessel for treatment of...
#2 - Transcatheter Mitral Valve therapy : repair or replace?
19 Oct 2021
Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.
Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel
26 Oct 2021
An active surveillance programme was initiated by the Israeli Ministry of Health to ascertain the possible causal relationship between the vaccine and myocarditis and evaluate incidence, clinical relevance, and related outcomes.
Reviewer
FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG
12 Nov 2021
Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial
04 Nov 2021
Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....
Author
AICT-AsiaPCR 2021 Opening Ceremony and APSIC Fellowship Ceremony
08 Oct 2021 – From AICT-AsiaPCR 2021
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes
04 Nov 2021
TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...
Author
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
